Meta-Analysis
Copyright ©The Author(s) 2021.
World J Gastroenterol. Apr 14, 2021; 27(14): 1507-1523
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1507
Table 3 Meta-analysis of outcomes (all studies included)
Period
Outcome
Studies
Participants
Effect size OR, 95%CI (fixed/random)
Heterogeneity
Test for overall effect (fixed/random)
Publication bias
Study quality1
Favors
1995-2010Overall biliary complications1012461.41 [0.66, 2.98]I2 = 85.4% (bP = 0.001)Z = 0.89/(P = 0.37)Egger: Bias = 1.92; P = 0.603 × 4, 2 × 1, 1 × 5None
Bile leak1113461.04 [0.63, 1.70]I2 = 16.7% (P = 0.29)Z = 0.14/(P = 0.89)Egger: Bias = 2.43; bP = 0.0033 × 4, 2 × 1, 1 × 6None
Biliary stricture1113460.62 [0.42, 0.90]I2 = 26.6% (P = 0.19)Z = 2.51/(aP = 0.012)Egger: Bias = -1.09; P = 0.563 × 4, 2 × 1, 1 × 6With T-tube
Cholangitis67252.00 [0.59, 6.84]I2 = 53.6% (P = 0.06)Z = 1.11/(P = 0.27)Egger: Bias = 2.97; aP = 0.023 × 4, 1 × 2None
2010-2020Overall biliarycomplications47631.49 [1.00, 2.22]I2 = 31.9% (P = 0.22)Z = 1.97/(aP = 0.049)Egger: Bias = 2.50; P = 0.223 × 1, 1 × 3Without T-tube
Bile leak68531.91 [1.01, 3.64]I2 = 6.0% (P = 0.38)Z = 1.98/(aP = 0.048)Egger: Bias = -1.69; P = 0.303 × 1, 2 × 2, 1×3Without T-tube
Biliary stricture68530.76 [0.27, 2.12]I2 = 62.3% (aP = 0.02)Z = 0.53/(P = 0.60)Egger: Bias = 0.84; P = 0.703 × 1, 2 × 2, 1 × 3None
Cholangitis37177.21 [1.37, 38.00]I2 = 0.0% (P = 0.52)Z = 2.33/(aP = 0.02)Egger: Bias = -12.51; P = 0.123 × 1, 1 × 2Without T-tube